Search research articles
Contact Us
Filters
Showing results (211-220 of 256) with videos related to
Page
of 26
Sort By:
Molecular and Cellular Endocrinology
|
June 9, 2026
The Mineralocorticoid Receptor and Its Antagonist Finerenone Regulate Hepatic Lipid Accumulation via the AMPK/SREBP1/FASN Signaling
Shanpan Fu, Mingyan Zhang, Kai Wang, et al.
Open Life Sciences
|
October 17, 2022
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Zhegang Zhang, Zheng Jiang, Tao Deng, et al.
Rheumatology (Oxford, England)
|
November 21, 2022
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study
Shuhui Hu, Mingshu Sun, Maichao Li, et al.
The Lancet. Infectious Diseases
|
November 20, 2020
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang, Gang Zeng, Hongxing Pan, et al.
Journal of Human Genetics
|
August 12, 2020
Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects
Riku Takei, Murray Cadzow, David Markie, et al.
Rheumatology (Oxford, England)
|
March 11, 2021
Effects of fenofibrate therapy on renal function in primary gout patients
Xinde Li, Wenyan Sun, Jie Lu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 7, 2022
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion
Fei Yan, Xiaomei Xue, Jie Lu, et al.
Lancet (London, England)
|
September 19, 2006
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
Jiangtao Lin, Jiansan Zhang, Xiaoping Dong, et al.
Human Vaccines & Immunotherapeutics
|
March 21, 2024
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
Shaomin Chen, Zhifang Ying, Yan Liu, et al.
Human Vaccines & Immunotherapeutics
|
March 12, 2014
Safety and immunogenicity of a live attenuated mumps vaccine: a phase I clinical trial
Yan Liang, Jingchen Ma, Changgui Li, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 256) with videos related to
Sort By:
Page
of 26
Molecular and Cellular Endocrinology
|
June 9, 2026
The Mineralocorticoid Receptor and Its Antagonist Finerenone Regulate Hepatic Lipid Accumulation via the AMPK/SREBP1/FASN Signaling
Shanpan Fu, Mingyan Zhang, Kai Wang, et al.
Open Life Sciences
|
October 17, 2022
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Zhegang Zhang, Zheng Jiang, Tao Deng, et al.
Rheumatology (Oxford, England)
|
November 21, 2022
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study
Shuhui Hu, Mingshu Sun, Maichao Li, et al.
The Lancet. Infectious Diseases
|
November 20, 2020
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang, Gang Zeng, Hongxing Pan, et al.
Journal of Human Genetics
|
August 12, 2020
Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects
Riku Takei, Murray Cadzow, David Markie, et al.
Rheumatology (Oxford, England)
|
March 11, 2021
Effects of fenofibrate therapy on renal function in primary gout patients
Xinde Li, Wenyan Sun, Jie Lu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 7, 2022
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion
Fei Yan, Xiaomei Xue, Jie Lu, et al.
Lancet (London, England)
|
September 19, 2006
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
Jiangtao Lin, Jiansan Zhang, Xiaoping Dong, et al.
Human Vaccines & Immunotherapeutics
|
March 21, 2024
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
Shaomin Chen, Zhifang Ying, Yan Liu, et al.
Human Vaccines & Immunotherapeutics
|
March 12, 2014
Safety and immunogenicity of a live attenuated mumps vaccine: a phase I clinical trial
Yan Liang, Jingchen Ma, Changgui Li, et al.
Page
of 26